FDA grants accelerated approval to Tazverik for relapsed/refractory follicular lymphoma June 19, 2020
Durvalumab/tremelimumab immunotherapy effective with chemotherapy in biliary tract cancer June 19, 2020
Neutralizing MAb from a convalescent patient inhibits SARS-CoV-2 infection in preclinical models June 19, 2020
New peripheral 5-HT2A antagonists for NAFLD treatment by structural modification of pimavanserin June 19, 2020
RSS